ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
+7.5%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$54.6M
AUM Growth
+$54.6M
(+42%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
25.44%
Top 10 Holdings %
Top 10 Hldgs %
73.49%
Holding
23
New
7
Increased
7
Reduced
5
Closed
4
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$5.59M |
| 2 |
Centene
CNC
|
$5.02M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$2.71M |
| 4 |
ALR
Alere Inc
ALR
|
$2.66M |
| 5 |
PTC Therapeutics
PTCT
|
$2.15M |
Top Sells
| 1 |
XNPT
XENOPORT, INC.
XNPT
|
$7.34M |
| 2 |
Quest Diagnostics
DGX
|
$2.34M |
| 3 |
Neurocrine Biosciences
NBIX
|
$1.48M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$996K |
| 5 |
QuidelOrtho
QDEL
|
$717K |
Sector Composition
| 1 | Healthcare | 90.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Centene
CNC
$14.3B
| $5.86M | 10.74% | 82,135 +70,285 | +593% | +$5.02M |
|
|
2
Jazz Pharmaceuticals
JAZZ
$7.75B
| $5.59M | 10.23% | +39,540 | New | +$5.59M |
|
3
Eli Lilly
LLY
$657B
| $4.64M | 8.51% | 58,965 -6,435 | -10% | -$507K |
|
|
4
Bio-Rad Laboratories Class A
BIO
$8.06B
| $4.44M | 8.13% | 31,029 +18,979 | +158% | +$2.71M |
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $4.19M | 7.68% | 83,502 +42,216 | +102% | +$2.12M |
|
|
NVRO
6
DELISTED
NEVRO CORP.
NVRO
| $3.74M | 6.84% | 50,633 +1,256 | +3% | +$92.7K |
|
7
UnitedHealth
UNH
$281B
| $3.34M | 6.12% | 23,648 +5,748 | +32% | +$812K |
|
|
8
Quest Diagnostics
DGX
$20.3B
| $2.84M | 5.2% | 34,843 -28,752 | -45% | -$2.34M |
|
9
Edwards Lifesciences
EW
$47.8B
| $2.82M | 5.16% | 28,270 +12,490 | +79% | +$1.25M |
|
|
ALR
10
DELISTED
Alere Inc
ALR
| $2.66M | 4.88% | +63,905 | New | +$2.66M |
|
|
11
PTC Therapeutics
PTCT
$3.92B
| $2.15M | 3.94% | +306,650 | New | +$2.15M |
|
12
Incyte
INCY
$16.5B
| $2.04M | 3.74% | +25,510 | New | +$2.04M |
|
|
IPXL
13
DELISTED
Impax Laboratories, Inc.
IPXL
| $2.02M | 3.71% | 70,235 +8,185 | +13% | +$236K |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.48M | 2.71% | 84,026 -56,561 | -40% | -$996K |
|
15
Pacira BioSciences
PCRX
$1.2B
| $1.41M | 2.58% | +41,707 | New | +$1.41M |
|
|
16
Neurocrine Biosciences
NBIX
$13.8B
| $1.39M | 2.55% | 30,671 -32,517 | -51% | -$1.48M |
|
17
Amicus Therapeutics
FOLD
$2.34B
| $1.25M | 2.3% | 229,626 -103,887 | -31% | -$567K |
|
|
SGYP
18
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $1.13M | 2.08% | +298,190 | New | +$1.13M |
|
19
OraSure Technologies
OSUR
$242M
| – | – | -69,200 | Closed | -$500K |
|
|
20
QuidelOrtho
QDEL
$1.95B
| – | – | -41,550 | Closed | -$717K |
|
|
XNPT
21
DELISTED
XENOPORT, INC.
XNPT
| – | – | -1,627,628 | Closed | -$7.34M |
|
|
ANAC
22
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| – | – | -8,850 | Closed | -$473K |
|